Company & Sponsor Intelligence
Aarhus University Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed0
Countries1
Therapeutic footprint
adhdepilepsyother_psychiatryparkinsons
Indexed studies
NCT04377425COVID-19 Prevalence and Cognitive Deficits in Neurological Patients
epilepsy · DenmarkWITHDRAWN
epilepsy · DenmarkWITHDRAWN
NCT05390268Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics
other_psychiatry · DenmarkNA
other_psychiatry · DenmarkNA
NCT04727476The Use of Lisdexamfetamine for Children Aged 7-13 With Attention Deficit Disorders
adhd · DenmarkUNKNOWN
adhd · DenmarkUNKNOWN
NCT02578849Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
parkinsons · DenmarkUNKNOWN
parkinsons · DenmarkUNKNOWN
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →